| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |